Point72 Asset Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-299,731
| Closed | -$701K | – | 1495 |
|
|
2022
Q3 | $701K | Buy |
299,731
+5,000
| +2% | +$11.7K | ﹤0.01% | 877 |
|
|
2022
Q2 | $893K | Buy |
294,731
+9,900
| +3% | +$30K | ﹤0.01% | 862 |
|
|
2022
Q1 | $1.93M | Buy |
284,831
+30,900
| +12% | +$210K | 0.01% | 801 |
|
|
2021
Q4 | $2.12M | Buy |
+253,931
| New | +$2.12M | 0.01% | 765 |
|
|
2020
Q1 | – | Sell |
-200,000
| Closed | -$1.75M | – | 1116 |
|
|
2019
Q4 | $1.75M | Buy |
+200,000
| New | +$1.75M | 0.01% | 599 |
|